Novocor Medical Systems
Novocor develops products that enable paramedics to treat cardiac arrest victim in the field by rapidly inducing hypothermia.
Every year 420K americans go into cardiac arrest and over 90% will die or suffer permanent brain damage. Clinical studies has shown the survival rate can be increased by 50% with rapid induction of therapeutic hypothermia (TH). Novocor develops products that enable paramedics to rapidly induce TH at the earliest possible moment, simultaneously with resuscitation efforts. The product will be sold directly to EMS agencies for use on ambulances.